Dr. Bodas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Perkins Sq
Akron, OH 44308Phone+1 330-543-8730Fax+1 330-543-3220
Education & Training
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Pediatric Hematology/Oncology, 2008 - 2011
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2005 - 2007
Case Western Reserve University School of MedicineClass of 2004
Certifications & Licensure
OH State Medical License 2008 - 2025
MA State Medical License 2007 - 2010- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Losartan to Reverse Sickle Nephropathy Start of enrollment: 2012 Feb 01
- Screening Patients With Sickle Cell Disease for Kidney Damage Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- Urinary Biomarkers for the Assessment of Acute Kidney Injury of Pediatric Sickle Cell Anemia Patients Admitted for Severe Vaso-occlusive Crises.Nicholas Farris, Stefanie W Benoit, Neil L McNinch, Prasad Bodas
Journal of Pediatric Hematology/oncology. 2023-08-01 - Comment on: Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.Prasad Bodas, Lauren Beck, Bobbi Moser, Joseph Delagrange
Pediatric Blood & Cancer. 2023-05-01 - 4 citationsAccuracy of online medical information: the case of social media in sickle cell disease.Nichole Slick, Prasad Bodas, Sherif M Badawy, Beth Wildman
Pediatric Hematology and Oncology. 2023-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
